Barinthus Share Price
NASDAQ: BRNS | Healthcare$0.00
+0.00 (0.00%) Barinthus Stock Performance
Barinthus Share Price Chart
$0.00$0.00
L
H
Barinthus Quarterly Profit & Loss
All figures in USD
Barinthus Annual Profit & Loss
All figures in USD
Barinthus Balance Sheet
All figures in USD Million
Barinthus Cash Flow
Annually
All figures in USD Million
About Barinthus
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.
Barinthus Historical Returns
| Month | Open | Close | Change % |
|---|